Position in CERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,626,203
+$2,355,653 QoQ
Shares Held
899,385
+505.0% QoQ
Ownership
0.446%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 186 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $5,538,832,166 across 47 Medical Devices names. CERS ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
18,806,911 | $1,706,539,098 | |
| 2 | MDT |
Medtronic plc
|
17,550,983 | $1,373,013,392 | |
| 3 | SYK |
Stryker Corp
|
2,787,785 | $877,706,223 | |
| 4 | BSX |
Boston Scientific Corp
|
13,772,323 | $587,802,740 | |
| 5 | BRKR |
Bruker Corp
|
3,429,337 | $283,923,498 | |
| 6 | DXCM |
Dexcom Inc
|
3,595,893 | $242,183,387 | |
| 7 | EW |
Edwards Lifesciences Corp
|
1,034,154 | $93,549,566 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
193,682 | $56,866,970 |
All Filings in CERS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,626,203 | 899,385 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $270,550 | 148,654 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $307,819 | 149,427 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $50,178 | 31,559 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $130,242 | 93,700 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $160,048 | 103,928 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $163,147 | 93,763 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $145,067 | 82,425 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $155,971 | 82,525 | Shares | Defined | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||